Laurel Oak Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.85M Buy
4,043
+147
+4% +$150K 0.71% 33
2026
Q1
$3.58M Buy
3,896
+104
+3% +$105K 0.6% 36
2025
Q4
$4.08M Buy
+3,792
New +$3.63M 0.69% 34

Other funds holding LLY

Laurel Oak Wealth Management's LLY Position: Q2 2026 in Review

Laurel Oak Wealth Management increased its Eli Lilly (LLY) stake by 3.8% in Q2 2026, buying an estimated $150K and bringing the position to 4,043 shares worth $4.85M. The position accounts for 0.71% of the portfolio, ranked #33.

Laurel Oak Wealth Management first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 1,716 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Laurel Oak Wealth Management held 4,043 shares of Eli Lilly worth $4.85M as of Q2 2026.
  • Laurel Oak Wealth Management bought 147 Eli Lilly shares in Q2 2026, an estimated $150K.
  • Eli Lilly made up 0.71% of Laurel Oak Wealth Management's portfolio in Q2 2026, its #33 holding.
  • Laurel Oak Wealth Management first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 1,716 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Laurel Oak Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.